All times shown are PDT (GMT-7) (San Francisco)

1. Major Industry Sponsor Satellites

Major industry sponsor satellite
Organizer
Johnson & Johnson/ Janssen Pharmaceuticals
Room
Satellite - On-demand Channel
Session Description
During this hour long discussion taking place on July 7th, award-winning journalist Lisa Ling will be interviewing community leaders, advocates and scientists to talk about why the development of an HIV vaccine remains an essential need, discuss how the learnings from the quest to develop an HIV vaccine are being applied to expedite the delivery of COVID-19 vaccines, explore why it is essential to ensure the representation of diverse individuals and communities in vaccine clinical trials, and highlight how we can empower self-care and best support the needs of those living with HIV during this unprecedented time. Audience members will be able to ask questions of this panel.
Major industry sponsor satellite
Organizer
Merck
Room
Satellite - On-demand Channel
Session Description
Carmen Villar, Merck's Vice President of Social Innovation, will host a fireside chat with Greg Millett, Vice President, Public Policy at amfAR, to discuss a paper he co-authored entitled, "COVID-19 Racial Disparities in U.S. Counties."
Major industry sponsor satellite
Organizer
Clinical Care Options; LLC
Room
Satellite - On-demand Channel
Session Description
Review key developments in ART management. This set of concise, on-demand talks from leading HIV faculty highlights how to (1) select among newer antiretrovirals and treatment paradigms, (2) individualize ART for women of childbearing potential and during pregnancy, (3) incorporate evolving data on ART-associated adverse events into patient care, and (4) anticipate the role of emerging investigational ART strategies. Watch these prerecorded foundational snippets to set the stage for a live case-based panel discussion on July 7. Supported by an educational grant from Merck Sharp & Dohme Corp.
Major industry sponsor satellite
Organizer
Gilead
Room
Satellite - On-demand Channel
Session Description

For decades, multisectoral alliances and partnerships have shaped the global response to HIV. Collaboration between a range of partners, leveraging the strengths of each one, continues to have a positive impact on HIV. Although steady progress has been made in ending the epidemic, gains have not been shared across all populations and geographic regions. This program examines how multisectoral alliances are helping to close the gaps in HIV prevention and treatment by multiplying impact and reach and addressing areas of unmet need. Moderator Vignetta Charles, PhD, CEO at ETR, explores the following successful partnerships with key stakeholders: DREAMS, with Angeli Achrekar, Principal Deputy US Global AIDS Coordinator (PEPFAR); MenStar Coalition with Lauren Marks, Director of Private Sector Engagement at PEPFAR; RADIAN, with Anne Aslett, Global Chief Executive Officer of the Elton John AIDS Foundation; and COMPASS Initiative, with Shanell McGoy, Associate Director for Public Affairs at Gilead Sciences, Inc.

Major industry sponsor satellite
Organizer
Gilead
Room
Satellite - On-demand Channel
Session Description

Over the past 4 decades, innovations in HIV prevention and treatment have helped shift the course of the HIV epidemic from a disease of high morbidity and mortality to one that is chronic and manageable for most. However, there are still gaps in care that must be overcome to adequately address the challenges faced by people living with and at risk of HIV. Jeffrey S. Crowley, MPH, Program Director of Infectious Disease Initiatives at the O’Neill Institute for National and Global Health Law at Georgetown University, and Christian Ramers, MD, MPH, AAHIVM, Assistant Medical Director for Research & Special Populations and Director of Graduate Medical Education at Family Health Centers of San Diego, discuss how innovations have driven changes in HIV care, and how telehealth might just be the next disruptive innovation in HIV management.

2. Commercial Satellites

Commercial Satellite
Organizer
A Shot in the Arm Podcast in partnership with the Bay Area Global Health Alliance
Room
Satellite - On-demand Channel
Session Description
In this special episode of A Shot In The Arm Podcast, produced in partnership with the Bay Area Global Health Alliance, we meet Dr Huma Abbasi, Chief Medical Officer and General Manager Enterprise Health at Chevron, to explore the company’s long heritage in the response to AIDS, and how partnerships can affect change in the fight against HIV, and how innovative solutions are needed for new challenges like COVID-19.

3. Non-Commercial Satellites

Non-Commercial Satellite
Organizer
HIV/AIDS SectionUnited Nations Office on Drugs and Crime
Room
Satellite Channel 2
Session Description
For many years, the focus on HIV prevention among people who use drugs has concentrated on the injection of opiates. While it is difficult to quantify the contribution the use of stimulants is making to the increase in HIV rates, evidence points towards a positive association between stimulant use, higher-risk sexual and injecting behaviors and HIV. Both non-injecting and injecting stimulant drug use has been associated with sexual transmission of HIV, particularly among men who have sex with men and sex workers. The overlapping risks between key populations are not sufficiently addressed by current interventions. Participants in the session will learn about how to address HIV among people who use stimulant drugs focusing on specific key populations (Men having Sex with Men, People Who Inject Drugs, Sex Workers, Transgender people). a) Overview of the epidemiological situation related to HIV and stimulant drug use b) Barriers and opportunities for addressing the specific needs of the key populations c) UNODC guide "HIV Prevention, Treatment, and Care for People Who Use Stimulant Drugs"
Non-Commercial Satellite
Organizer
Measurement & Surveillance of HIV Epidemics Consortium at the London School of Hygiene & Tropical Medicine
Room
Satellite - On-demand Channel
Session Description
Tracking and accelerating HIV incidence reduction is the most pressing concern for the global HIV community. If we are to achieve epidemic control, the ease with which we attain and understand epidemiological estimates must improve. This session is targeted towards delegates interested in understanding where we are at and where we are going in achieving precision in our understanding of HIV epidemiology to inform programming. The 40-minute pre-recorded session will provide an introduction to the Measurement & Surveillance of HIV Epidemics (MeSH) and HIV Modelling consortia, including examples of some recent work on HIV & COVID-19. There will also be a presentation, focusing on Malawi, on how new technologies may be utilised in monitoring and measurement activities. The 60 minute live session consists of two presentations from leading experts, addressing critical questions and new methods for attaining robust, sustainable HIV-epidemiology estimates in southern Africa. These will be followed by a panel discussion.
Non-Commercial Satellite
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite - On-demand Channel
Session Description
The global UNAIDS target is 3 million active PrEP users by the end of 2020 but as of June there were only an estimated 575,000 enrolled. Despite slow roll-out initially, there are now at least 78 countries offering PrEP but with less diversity in service models than seen in differentiated ART delivery. Pre-COVID-19, there was a move towards more community-based or virtual/Telehealth models that have since been accelerated during COVID-19 country lock-downs. In this session, we will highlight how some countries have rapidly pivoted PrEP programming be more differentiated and truly client-centered—offering online, community, and private-sector service options to expand and maintain access. In the live session, perspectives from providers, PrEP users, ministry of health, and global normative agencies will also be shared with a moderated discussion on how a differentiated approach to PrEP will be essential to significantly increase uptake by the end of 2020 and beyond!
Non-Commercial Satellite
Organizer
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)
Room
Satellite - On-demand Channel
Session Description
In order to end the HIV epidemic among adolescents and young adults in the US, the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) recognizes the central role that community members and youth must play in research. In this session, Manuel Ocasio will provide a window into the community of sexual and gender minority youth in New Orleans and three ATN youth representatives - Ron Smalls, Booker Shorter, and Daniel Rodriguez - will share their perspectives on methods for engaging and retaining youth in research.
Non-Commercial Satellite

HIV-Sensitive Social Protection in Humanitarian Settings:How can integration help end AIDS by 2030?

Organizer
World Food Programme
Room
Satellite - On-demand Channel
Session Description
Addressing the needs of the millions of people around the world affected by humanitarian emergencies will be critical to meet the Fast-Track targets of ending AIDS by 2030. To avoid losing the hard-won gains made so far in the fight against HIV/AIDS, all co-sponsors of the Joint United Nations Programme on HIV/AIDS (UNAIDS) will need to step up and strengthen efforts to adequately incorporate -sensitive social protection into humanitarian and emergency responses, including in preparedness actions. The session is an opportunity to learn about the role of social protection in delivering support to people living with, affected by, and at risk of HIV in humanitarian crisis. The session will also provide a platform to share examples of programmatic interventions and transfer modalities (e.g. cash based transfers), studies, analyses, and guidance, including mapping of the current food and nutrition assistance in refugee camps, and examples of how technology can be leveraged to facilitate beneficiaries’ access to HIV care.
Non-Commercial Satellite
Organizer
California HIV/AIDS Research Program
Room
Satellite - On-demand Channel
Session Description
The California HIV/AIDS Research Program funded three demonstration projects focused on increasing access, uptake, and adherence to PrEP among transgender individuals in California. These were the first PrEP demonstration projects in the U.S. focused specifically on transgender communities. The 3 research teams, two from the San Francisco Bay Area and one from San Diego/Los Angeles, aimed to provide PrEP to a combined 700 transgender and non-binary individuals, with particular focus on transgender women of color. PrEP provision was included as part of a comprehensive prevention and sexual health package. Gilead Sciences provided the Truvada? for the studies. The session will feature presentations from each of the research projects and highlight the various models of PrEP delivery used, facilitators and barriers to PrEP uptake and adherence, early findings from pharmacokinetic studies on PrEP and hormone interactions, and other key lessons learned throughout the different studies.